West Paces Advisors’s Edwards Lifesciences EW Stock Holding History

West Paces Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.98K	Sell	23 -10	-30%	-$889	﹤0.01%	579
2026 Q2	$2.98K	Buy	+33	New	+$2.76K	﹤0.01%	525
2022 Q4	–	Sell	-72	Closed	-$5.95K	–	542
2022 Q3	$5.95K	Hold	72	–	–	﹤0.01%	377
2022 Q2	$6.85K	Hold	72	–	–	﹤0.01%	392
2022 Q1	$8.48K	Hold	72	–	–	﹤0.01%	380
2021 Q4	$9.33K	Sell	72 -30	-29%	-$3.5K	﹤0.01%	383
2021 Q3	$11.5K	Hold	102	–	–	﹤0.01%	346
2021 Q2	$10.6K	Hold	102	–	–	﹤0.01%	353
2021 Q1	$8.53K	Hold	102	–	–	﹤0.01%	345
2020 Q4	$9.3K	Hold	102	–	–	﹤0.01%	323
2020 Q3	$8.14K	Hold	102	–	–	﹤0.01%	322
2020 Q2	$7.05K	Hold	102	–	–	﹤0.01%	344
2020 Q1	$6.41K	Hold	102	–	–	﹤0.01%	340
2019 Q4	$7.93K	Hold	102	–	–	﹤0.01%	370
2019 Q3	$7.48K	Hold	102	–	–	﹤0.01%	352
2019 Q2	$6.28K	Hold	102	–	–	﹤0.01%	361
2019 Q1	$6.5K	Hold	102	–	–	﹤0.01%	361
2018 Q4	$5.21K	Hold	102	–	–	﹤0.01%	374
2018 Q3	$5.92K	Hold	102	–	–	﹤0.01%	366
2018 Q2	$4.95K	Buy	102 +30	+42%	+$1.4K	﹤0.01%	385
2018 Q1	$3.35K	Hold	72	–	–	﹤0.01%	396
2017 Q4	$2.7K	Sell	72 -84	-54%	-$3.08K	﹤0.01%	416
2017 Q3	$5.68K	Sell	156 -69	-31%	-$2.63K	﹤0.01%	378
2017 Q2	$8.87K	Hold	225	–	–	0.01%	349
2017 Q1	$7.06K	Sell	225 -27	-11%	-$845	0.01%	362
2016 Q4	$7.87K	Buy	+252	New	+$8.16K	0.01%	363

Other funds holding EW

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One North America New York $2.13B AUM 8.8% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

West Paces Advisors's EW Position: Q3 2026 in Review

West Paces Advisors reduced its Edwards Lifesciences (EW) stake by 30% in Q3 2026, selling an estimated $889 and leaving 23 shares worth $1.98K. The position accounts for ﹤0.01% of the portfolio, ranked #579.

West Paces Advisors first reported a position in EW in Q4 2016 and has held it in 26 quarters since. The position peaked at $11.5K in Q3 2021. 326 funds tracked by Wall St. Rank hold EW as of Q3 2026.

West Paces Advisors held 23 shares of Edwards Lifesciences worth $1.98K as of Q3 2026.
West Paces Advisors sold 10 Edwards Lifesciences shares in Q3 2026, an estimated $889.
Edwards Lifesciences made up ﹤0.01% of West Paces Advisors's portfolio in Q3 2026, its #579 holding.
West Paces Advisors first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 26 quarters since.
West Paces Advisors's Edwards Lifesciences position peaked at $11.5K in Q3 2021.
326 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on West Paces Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.